Morgan Stanley’s ThermoGenesis Holdings, Inc. Common Stock THMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,295
Closed -$6.64K 8008
2024
Q1
$6.64K Sell
9,295
-9,293
-50% -$6.34K ﹤0.01% 6822
2023
Q4
$11.2K Buy
18,588
+9,294
+100% +$8.92K ﹤0.01% 6809
2023
Q3
$12.8K Hold
9,294
﹤0.01% 6643
2023
Q2
$11.9K Buy
9,294
+7,751
+502% +$13.5K ﹤0.01% 6751
2023
Q1
$4.04K Sell
1,543
-1,094
-41% -$3.81K ﹤0.01% 7101
2022
Q4
$8.44K Buy
2,637
+2,469
+1,470% +$16.2K ﹤0.01% 6993
2022
Q3
$2K Hold
168
﹤0.01% 7503
2022
Q2
$2K Sell
168
-5
-3% -$99 ﹤0.01% 7620
2022
Q1
$5K Buy
173
+1
+0.6% +$36 ﹤0.01% 7598
2021
Q4
$8K Sell
172
-4
-2% -$262 ﹤0.01% 7546
2021
Q3
$16K Sell
176
-1
-0.6% -$104 ﹤0.01% 7182
2021
Q2
$21K Buy
177
+131
+285% +$15.5K ﹤0.01% 6996
2021
Q1
$6K Hold
46
﹤0.01% 7075
2020
Q4
$4K Sell
46
-12
-21% -$1.28K ﹤0.01% 6817
2020
Q3
$8K Buy
58
+5
+9% +$981 ﹤0.01% 6342
2020
Q2
$13K Buy
53
+43
+430% +$13.3K ﹤0.01% 6107
2020
Q1
$2K Buy
10
+5
+100% +$933 ﹤0.01% 6415
2019
Q4
$1K Sell
5
-30
-86% -$5.79K ﹤0.01% 6603
2019
Q3
$10K Buy
35
+29
+483% +$4.72K ﹤0.01% 6213
2019
Q2
$1K Buy
+6
New +$760 ﹤0.01% 6586
2016
Q1
Sell
-2
Closed -$3K 6754
2015
Q4
$3K Hold
2
﹤0.01% 6468
2015
Q3
$9K Hold
2
﹤0.01% 6267
2015
Q2
$15K Hold
2
﹤0.01% 6206
2015
Q1
$16K Hold
2
﹤0.01% 6121
2014
Q4
$18K Hold
2
﹤0.01% 6082
2014
Q3
$22K Buy
2
+1
+100% +$12K ﹤0.01% 5979
2014
Q2
$16K Hold
1
﹤0.01% 6082
2014
Q1
$19K Hold
1
﹤0.01% 5976
2013
Q4
$5K Buy
+1
New +$7.94K ﹤0.01% 6157
2013
Q3
Sell
-1
Closed -$16K 5399
2013
Q2
$16K Buy
+1
New +$9.13K ﹤0.01% 5288

Other funds holding THMO

Morgan Stanley's THMO Position: Q2 2024 in Review

Morgan Stanley sold out of ThermoGenesis Holdings, Inc. Common Stock (THMO) in Q2 2024, closing a stake of 9,295 shares — an estimated $6.64K sold.

Morgan Stanley first reported a position in THMO in Q2 2013 and held it in 30 quarters. The position peaked at $22K in Q3 2014. 2 funds tracked by Wall St. Rank hold THMO as of Q2 2024.

  • Morgan Stanley reported no remaining ThermoGenesis Holdings, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Morgan Stanley sold 9,295 ThermoGenesis Holdings, Inc. Common Stock shares in Q2 2024, an estimated $6.64K.
  • Morgan Stanley first reported a position in ThermoGenesis Holdings, Inc. Common Stock in Q2 2013 and held it in 30 quarters.
  • Morgan Stanley's ThermoGenesis Holdings, Inc. Common Stock position peaked at $22K in Q3 2014.
  • 2 funds tracked by Wall St. Rank held ThermoGenesis Holdings, Inc. Common Stock as of Q2 2024.

Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.